全文获取类型
收费全文 | 198篇 |
免费 | 9篇 |
专业分类
儿科学 | 2篇 |
妇产科学 | 2篇 |
基础医学 | 11篇 |
口腔科学 | 4篇 |
临床医学 | 30篇 |
内科学 | 50篇 |
神经病学 | 30篇 |
特种医学 | 19篇 |
外科学 | 22篇 |
综合类 | 8篇 |
预防医学 | 13篇 |
药学 | 14篇 |
肿瘤学 | 2篇 |
出版年
2023年 | 1篇 |
2022年 | 4篇 |
2021年 | 13篇 |
2020年 | 13篇 |
2019年 | 14篇 |
2018年 | 13篇 |
2017年 | 8篇 |
2016年 | 3篇 |
2015年 | 4篇 |
2014年 | 8篇 |
2013年 | 7篇 |
2012年 | 13篇 |
2011年 | 12篇 |
2010年 | 7篇 |
2009年 | 7篇 |
2008年 | 12篇 |
2007年 | 14篇 |
2006年 | 6篇 |
2005年 | 9篇 |
2004年 | 10篇 |
2003年 | 8篇 |
2002年 | 4篇 |
2001年 | 1篇 |
2000年 | 1篇 |
1999年 | 1篇 |
1998年 | 1篇 |
1997年 | 2篇 |
1996年 | 1篇 |
1991年 | 1篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1982年 | 3篇 |
1980年 | 1篇 |
1979年 | 1篇 |
1973年 | 1篇 |
排序方式: 共有207条查询结果,搜索用时 15 毫秒
1.
Predictors and outcomes of unplanned early rehospitalization in the first year following lung transplantation 下载免费PDF全文
Andrew M. Courtwright Stacey Salomon Anne Fuhlbrigge Miguel Divo Ivan O. Rosas Phillip C. Camp Hari H. Mallidi Patrick Burkett Souheil El‐Chemaly David J. Wolfe Hilary J. Goldberg 《Clinical transplantation》2016,30(9):1053-1058
Unplanned early rehospitalization (UER), defined as an unscheduled admission within 30 days of a hospital discharge, is associated with graft loss and recipient mortality in some solid organ transplants but has not been investigated in lung transplant. In this retrospective study, we collected socio‐demographic and clinical factors to determine predictors and outcomes of UER in the first year following lung transplantation. There were 193 patients who underwent lung transplantation and survived to discharge during the 7.9‐year study period. There were 116 (60.1%) patients with at least one UER. Infections (32.8%) and post‐surgical complications (11.8%) were the most common reasons for UER. On multivariate analysis, the strongest predictor of having an UER was discharge to a long‐term acute care facility (odds ratio: 3.01, 95% confidence interval [CI] 1.46–6.20; P=.003). Patients with any UER in the first year following transplantation had worse adjusted survival (hazard ratio: 1.89, 95% CI 1.02–3.50; P=.04). It is unclear, however, to what extent UERs reflect preventable outcomes. Further large‐scale, prospective research is needed to identify the extent to which certain types of UER are modifiable and to define patients at high‐risk for preventable UER. 相似文献
2.
Ahmed Kamel Abdel-Aal Souheil Saddekni Maysoon Farouk Hamed Farley Fitzpatrick 《Cardiovascular and interventional radiology》2013,36(2):558-560
Entrapment of a central venous catheter (CVC) guide wire in an inferior vena cava (IVC) filter is a rare, but reported complication during CVC placement. With the increasing use of vena cava filters (VCFs), this number will most likely continue to grow. The consequences of this complication can be serious, as continued traction upon the guide wire may result in filter dislodgement and migration, filter fracture, or injury to the IVC. We describe a case in which a J-tipped guide wire introduced through a left subclavian access without fluoroscopic guidance during CVC placement was entrapped at the apex of an IVC filter. We describe a technique that we used successfully in removing the entrapped wire through the left subclavian access site. We also present simple useful recommendations to prevent this complication. 相似文献
3.
4.
5.
6.
Wijkstrom-Frei C El-Chemaly S Ali-Rachedi R Gerson C Cobas MA Forteza R Salathe M Conner GE 《American journal of respiratory cell and molecular biology》2003,29(2):206-212
The lactoperoxidase (LPO) antibiotic system is a well-characterized component of mammary and salivary gland secretions. Because LPO has been shown to function in ovine airways, human airway tissue and secretions were examined for the presence of LPO and its substrate, the anion thiocyanate (SCN-). In addition, human airway secretions were tested for LPO-mediated antibacterial activity, and LPO's activity was assessed against some human airway pathogens. The data showed that normal human airway secretions contained LPO enzyme activity (0.65 +/- 0.09 microg/mg secreted protein; n = 17), and Western blots of secretions demonstrated bands of the expected sizes for LPO. LPO mRNA was detected in trachea by sequencing PCR-amplified cDNA. SCN-, LPO's substrate, was present in undiluted airway secretions at concentrations sufficient for LPO catalysis (0.46 +/- 0.19 mM; n = 8), and diluted secretions contained antibacterial activity with LPO-like properties. Immunocytochemistry localized LPO to submucosal glands in human bronchi. Finally, as expected based on the known antibacterial spectrum of the LPO system, airway secretions showed LPO-dependent activity against Pseudomonas aeruginosa. In addition, the airway LPO system was shown to be effective against Burkholderia cepacia and Haemophilus influenzae. Thus, a functional LPO system exists in human airways and may contribute to airway host defense against infection. 相似文献
7.
8.
Michael D. Dake Timothy P. Murphy Albrecht H. Krämer Michael D. Darcy Luke E. Sewall Michael A. Curi Matthew S. Johnson Frank Arena James L. Swischuk Gary M. Ansel Mitchell J. Silver Souheil Saddekni Jayson S. Brower Robert Mendes 《Journal of vascular and interventional radiology : JVIR》2018,29(10):1350-1361.e4
Purpose
To prospectively assess the Sentry bioconvertible inferior vena cava (IVC) filter in patients requiring temporary protection against pulmonary embolism (PE).Materials and Methods
At 23 sites, 129 patients with documented deep vein thrombosis (DVT) or PE, or at temporary risk of developing DVT or PE, unable to use anticoagulation were enrolled. The primary end point was clinical success, including successful filter deployment, freedom from new symptomatic PE through 60 days before filter bioconversion, and 6-month freedom from filter-related complications. Patients were monitored by means of radiography, computerized tomography (CT), and CT venography to assess filtering configuration through 60 days, filter bioconversion, and incidence of PE and filter-related complications through 12 months.Results
Clinical success was achieved in 111 of 114 evaluable patients (97.4%, 95% confidence interval [CI] 92.5%–99.1%). The rate of freedom from new symptomatic PE through 60 days was 100% (n = 129, 95% CI 97.1%–100.0%), and there were no cases of PE through 12 months for either therapeutic or prophylactic indications. Two patients (1.6%) developed symptomatic caval thrombosis during the first month; neither experienced recurrence after successful interventions. There was no filter tilting, migration, embolization, fracture, or caval perforation by the filter, and no filter-related death through 12 months. Filter bioconversion was successful for 95.7% (110/115) at 6 months and for 96.4% (106/110) at 12 months.Conclusions
The Sentry IVC filter provided safe and effective protection against PE, with a high rate of intended bioconversion and a low rate of device-related complications, through 12 months of imaging-intense follow-up. 相似文献9.